JPWO2021092322A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021092322A5 JPWO2021092322A5 JP2022526226A JP2022526226A JPWO2021092322A5 JP WO2021092322 A5 JPWO2021092322 A5 JP WO2021092322A5 JP 2022526226 A JP2022526226 A JP 2022526226A JP 2022526226 A JP2022526226 A JP 2022526226A JP WO2021092322 A5 JPWO2021092322 A5 JP WO2021092322A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- subject
- cell
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025089886A JP2025143254A (ja) | 2019-11-06 | 2025-05-29 | がん幹細胞を標的化するがん治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962931531P | 2019-11-06 | 2019-11-06 | |
| US62/931,531 | 2019-11-06 | ||
| PCT/US2020/059329 WO2021092322A1 (en) | 2019-11-06 | 2020-11-06 | Cancer treatments targeting cancer stem cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025089886A Division JP2025143254A (ja) | 2019-11-06 | 2025-05-29 | がん幹細胞を標的化するがん治療 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022553865A JP2022553865A (ja) | 2022-12-26 |
| JPWO2021092322A5 true JPWO2021092322A5 (https=) | 2023-11-14 |
| JP2022553865A5 JP2022553865A5 (https=) | 2023-11-14 |
| JP7690470B2 JP7690470B2 (ja) | 2025-06-10 |
Family
ID=73643356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526226A Active JP7690470B2 (ja) | 2019-11-06 | 2020-11-06 | がん幹細胞を標的化するがん治療 |
| JP2025089886A Pending JP2025143254A (ja) | 2019-11-06 | 2025-05-29 | がん幹細胞を標的化するがん治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025089886A Pending JP2025143254A (ja) | 2019-11-06 | 2025-05-29 | がん幹細胞を標的化するがん治療 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP4055008A1 (https=) |
| JP (2) | JP7690470B2 (https=) |
| KR (1) | KR20220110744A (https=) |
| CN (2) | CN119930509A (https=) |
| AU (1) | AU2020378067A1 (https=) |
| BR (1) | BR112022008753A2 (https=) |
| CA (1) | CA3157315A1 (https=) |
| CO (1) | CO2022007910A2 (https=) |
| IL (1) | IL292718A (https=) |
| MX (1) | MX2022005445A (https=) |
| PH (1) | PH12022551081A1 (https=) |
| WO (1) | WO2021092322A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102831570B1 (ko) | 2018-05-04 | 2025-07-10 | 레미디 플랜, 인크. | 암 줄기 세포를 표적화하는 암 치료 |
| JP2024518089A (ja) * | 2021-05-13 | 2024-04-24 | リメディー プラン，インコーポレーテッド | Ｎａｍｐｔ阻害剤とその使用 |
| WO2024049225A1 (ko) | 2022-09-01 | 2024-03-07 | 주식회사 엘지에너지솔루션 | 이차 전지 및 이를 포함하는 디바이스 |
| CN116139141A (zh) * | 2022-12-14 | 2023-05-23 | 复旦大学 | Agk2促进肝癌的免疫治疗的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19624659A1 (de) | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
| DE19624668A1 (de) | 1996-06-20 | 1998-02-19 | Klinge Co Chem Pharm Fab | Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden |
| WO2008016643A2 (en) * | 2006-08-01 | 2008-02-07 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
| WO2008026018A1 (en) | 2006-09-01 | 2008-03-06 | Topotarget Switzerland Sa | New method for the treatment of inflammatory diseases |
| FR2921657A1 (fr) * | 2007-09-28 | 2009-04-03 | Sanofi Aventis Sa | Derives de nicotinamide, leur preparation et leur application en therapeutique |
| EP2098231A1 (en) | 2008-03-05 | 2009-09-09 | Topotarget Switzerland SA | Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury |
| CA2877474A1 (en) * | 2011-06-20 | 2012-12-27 | Myrexis, Inc. | Compounds and therapeutic uses thereof |
| HK1211832A1 (zh) | 2012-05-07 | 2016-10-14 | The General Hospital Corporation | 用於癌症療法的抗高血壓藥物的新穎配方及用法 |
| ES2774330T3 (es) | 2013-04-09 | 2020-07-20 | Massachusetts Inst Technology | Polímero de suministro de fármaco y usos del mismo |
| TW201625641A (zh) * | 2014-05-22 | 2016-07-16 | 健臻公司 | Ｎａｍｐｔ抑制劑及方法 |
| US11078195B2 (en) * | 2016-03-17 | 2021-08-03 | Checkmate Therapeutics Inc. | Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same |
| KR102831570B1 (ko) * | 2018-05-04 | 2025-07-10 | 레미디 플랜, 인크. | 암 줄기 세포를 표적화하는 암 치료 |
-
2020
- 2020-11-06 AU AU2020378067A patent/AU2020378067A1/en active Pending
- 2020-11-06 EP EP20816347.7A patent/EP4055008A1/en active Pending
- 2020-11-06 CA CA3157315A patent/CA3157315A1/en active Pending
- 2020-11-06 MX MX2022005445A patent/MX2022005445A/es unknown
- 2020-11-06 PH PH1/2022/551081A patent/PH12022551081A1/en unknown
- 2020-11-06 KR KR1020227018395A patent/KR20220110744A/ko active Pending
- 2020-11-06 JP JP2022526226A patent/JP7690470B2/ja active Active
- 2020-11-06 BR BR112022008753A patent/BR112022008753A2/pt unknown
- 2020-11-06 WO PCT/US2020/059329 patent/WO2021092322A1/en not_active Ceased
- 2020-11-06 CN CN202510009927.XA patent/CN119930509A/zh active Pending
- 2020-11-06 CN CN202080091217.1A patent/CN114929672B/zh active Active
-
2022
- 2022-05-03 IL IL292718A patent/IL292718A/en unknown
- 2022-06-03 CO CONC2022/0007910A patent/CO2022007910A2/es unknown
-
2025
- 2025-05-29 JP JP2025089886A patent/JP2025143254A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025143254A5 (https=) | ||
| EP4328224A1 (en) | Parp inhibitor containing piperazine structure, preparation method therefor and pharmaceutical use thereof | |
| TWI880702B (zh) | 作為nrf2活化劑之羥基吡啶并氧氮呯 | |
| RU2683566C1 (ru) | Производное с сочлененными кольцами и способ его получения, промежуточное соединение, фармацевтическая композиция и их применение | |
| CN118434725B (zh) | 吡啶酰胺类parp抑制剂、及其制备方法和医药用途 | |
| WO2021073498A1 (zh) | Egfr抑制剂、组合物及其制备方法 | |
| US20230109134A1 (en) | Pyridazinone or pyridazine compound and derivative and pharmaceutical composition thereof | |
| JP2018510184A5 (https=) | ||
| JP7222590B2 (ja) | ３－アザビシクロ［３，１，１］ヘプタン誘導体及びこれを含む薬学的組成物 | |
| JPH04230389A (ja) | ラパマイシン誘導体 | |
| AU2009260060B2 (en) | Thiazolyl- and oxazolyl-isoquinolinones and methods for using them | |
| TWI706951B (zh) | 一種週期素依賴性蛋白激酶抑制劑的羥乙基磺酸鹽、其結晶形式及製備方法 | |
| CN117088878A (zh) | 一种高活性Wnt通路抑制剂化合物 | |
| TR201807104T4 (tr) | Sikloalkil asit türevi, bunun hazırlanış yöntemi ve farmasötik uygulaması. | |
| JP2023511302A (ja) | 新規なピラゾール誘導体 | |
| JP2023548148A (ja) | 置換ピラゾロピリミジンの固体形態及びその使用 | |
| JP2017510657A (ja) | Ｍｉｆ阻害剤 | |
| JPWO2021092322A5 (https=) | ||
| JP2023505238A (ja) | 新規ピロール化合物 | |
| CN120051467A (zh) | 2(1h)-吡啶亚胺衍生物 | |
| JP5378499B2 (ja) | 微小管形成阻害剤として有用なベンゾフェノンチアゾール誘導体及びその製造方法 | |
| CN107778336B (zh) | 吡喃葡萄糖基衍生物的结晶形式 | |
| AU2020289909A1 (en) | Antihypertensive polyol compound and derivative thereof | |
| TW202400572A (zh) | Erk的吡咯抑制劑之氘化類似物、其合成及其中間物 | |
| EP2313418B1 (en) | Thienyl- and furanyl-isoquinolinones and methods for using them |